- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Aetna (AET) To Remain Weak: Barron’s
Recent Articles by Ed Liston
- Regulators Failed During The Financial Crisis Due To Complacency; Alan Greenspan (JPM)
- Court Asks Fed To Disclose Records Of $2 Trillion U.S. Loan Program Launched After Lehman Collapse (OPY)
- Boeing (BA) Plans To Raise Production Of 777s And 747s Sooner-Than-Expected
- Metabolix, Inc. (MBLX) Maintains Market Weight Rating
- Pressure Mounts On EU To Create A System To Handle Failure Of Large Banks
Company News
- Tiffany Reports Earnings Monday Morning (TIF)
- Carl Icahn Makes Hostile Takeover Bid For Lions Gate Entertainment (LGF)
- Ex-Cadbury Executive To Head Kraft’s Confectionery Unit (KFT)
- Morningstar Acquires Realpoint LLC (MORN)
- Pfizer Eyes German Drug Maker Stada (PFE, TEVA)
Earnings
- Tiffany Reports Earnings Monday Morning (TIF)
- Top Performing Industries For March 19 (CNC, HANS, CAJ, BBY, GENT)
- CTAS Well Positioned To Pursue Acquisitions
- Stocks That Created New 52-Week Highs (LOPE, HBOS, HDSN, ITMN, INET)
- Benzinga’s Volume Movers (CTEL, IPSU, HANS, TEVA, TRMB)
Barron's
- Lowe’s (LOW) Could See Faster Growth Than Rival; Barron’s
- Dr Pepper (DPS) Pouring Out Sweet Returns For Investors; Barron’s
- Barron’s: Stock Market In Rare Mode Of Being Tired And Excited
- Top 10 Places In U.S. To Build Second Homes; Barron’s
- Barron’s: Sprint May Go Through Rough Weather In Coming Years
Markets
- USD Starting a New Wave Up?
- Carter Worth Says Best Buy Losing Momentum (BBY)
- Icahn Offers To Purchase All Outstanding Shares Of Lions Gate (LGF)
- Biotech Stock Mailbag: Generex (PFE, MNKD)
- VIX Lurching Higher Off Historical Support On Greece Worries (VIX)
Media
- Jim Cramer's Lightning Round Picks (APD, WEN, MCD, TSRA, VSI, VITC, PTV, IP, STXS, ABT, NMM, ATPG, GMCR)
- Fast Money Picks For March 22nd (MHS, CVS)
- Pressure Mounts On EU To Create A System To Handle Failure Of Large Banks
- Lowe’s (LOW) Could See Faster Growth Than Rival; Barron’s
- Dr Pepper (DPS) Pouring Out Sweet Returns For Investors; Barron’s
Posted on 02/08/10 at 3:53pm by Ed Liston
Aetna (NYSE: AET) announced lower-than-expected Q4 earnings. Its profit figure was down by 14.8% to $165.9 million. However, its revenue rose to $8.76 billion, surpassing estimates. Market estimates had pegged the revenue figure at $8.55 billion.
Its shares are currently trading at the multiple of 10X. According to Barron’s, Aetna is currently trading at a premium in comparison to its peers and the premium is not justified. Aetna is further expected to deteriorate on account of the health care bill provisions. Aetna’s EPS growth is likely to remain flat in 2010.
Bookmark/Search this post with:
Related Articles
- Oskosh Corporation May Be In Trouble, Says Barron's
- Boston Scientific (BSX) Disappoints Investors, According To Barron’s
- Intel’s (INTC) Business Rebounding, Says A Barron's Report
- Barrons Expects United Parcel Service (UPS) Stock To React Positively Towards Fourth Quarter Guidance
- Barron's Expects Apple (AAPL), Google (GOOG) To Benefit From Cloud Computing
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
